Author

S. Mallawarachchi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. Martina· 1 shared D. Ruzek· 1 shared H. Wang· 1 shared N. S. Mulgaonkar· 1 shared S. Fernando· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Martina

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19

N. S. Mulgaonkar, H. Wang, S. Mallawarachchi, D. Ruzek, B. Martina, S. Fernando

This paper reports that imatinib, an FDA-approved Bcr-Abl inhibitor, inhibits SARS-CoV-2 and other coronaviruses by blocking viral membrane fusion, suggesting its potential as a repurposed drug for COVID-19.

bioRxiv · Jun 18, 2020Microbiology